A round up of all the news on www.globalcorporateventuring.com for our subscribers.
Author: Callum Cyrus
HawkEye 360 turns to Raytheon
Raytheon led a $5.3m second tranche of a $14.9m series A-3 round for the RF signal analytics system developer.
Interview: Michael Lohnert, Boeing HorizonX Ventures
Michael Lohnert, investment director at Boeing HorizonX Ventures, touted the potential of low earth orbit (Leo) satellite technologies but also expressed concern that some founders in the space have underestimated the difficulty of delivering solutions to market
News round up 10 September 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
News round up 3 September 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Blickfeld catches another glimpse of seed round
Lidar technology developer Blickfeld has secured a $5.7m extension from investors including Unternehmertum Venture Capital Partners to bring its seed round to $10m.
Apogen ups series B round to $11m
Apogen Biotechnologies, a US-based oncology therapy spinout of University of Minnesota, boosted its series A round to $11m yesterday with $4m from investors including pharmaceutical firm Merck Group. Merck invested through corporate venturing subsidiary M Ventures, participating alongside unnamed existing investors. Pharmaceutical firms Eli Lilly, WuXi AppTec, AbbVie and Johnson & Johnson all contributed to… Continue reading Apogen ups series B round to $11m
News round up 28 August 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Certa makes new funding certain
Uniseed and the Australian government-backed MRCF have invested $18.5m in kidney disease drug developer Certa
News round up 20 August 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
News round up 13 August 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Apica accepts SEB investment
SEB subsidiary SEB Venture Capital contributed to a $12.7m round for the software performance-monitoring technology developer, which has raised $35m in total.
News round up 6 August 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Healthmyne drills into $15m series B
Ascension Ventures led a round that will fund the overseas commercialisation of Healthmyne’s cancer imaging analysis software.